Abstract
Increasing evidence of regional pathogen transmission networks highlights the importance of investigating the dissemination of multidrug-resistant organisms (MDROs) across a region to identify where transmission is occurring and how pathogens move across regions. We developed a framework for investigating MDRO regional transmission dynamics using whole-genome sequencing data and created regentrans, an easy-to-use, open source R package that implements these methods (https://github.com/Snitkin-Lab-Umich/regentrans). Using a dataset of over 400 carbapenem-resistant Klebsiella pneumoniae isolates collected from patients in 21 long-term acute care hospitals over a one-year period, we demonstrate how to use our framework to gain insights into differences in inter- and intra-facility transmission across different facilities and over time. This framework and corresponding R package will allow investigators to better understand the origins and transmission patterns of MDROs, which is the first step in understanding how to stop transmission at the regional level.
Impact statement Increasing evidence suggests that pathogen transmission occurs across healthcare facilities. Genomic epidemiologic investigations into regional transmission shed light on potential drivers of regional prevalence and can inform coordinated interventions across healthcare facilities to reduce transmission. Here we present a framework for studying regional pathogen transmission using whole-genome sequencing data, and a corresponding open-source R package, regentrans, that implements these methods to streamline analyses and make them more accessible to other researchers and public health practitioners. We also discuss how these methods can be extended to study transmission in other settings.
Data summary The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files.
The regentrans R package can be downloaded from GitHub: https://github.com/Snitkin-Lab-Umich/regentrans/
The manuscript figures are generated from regentrans example data and can also be found on GitHub: https://github.com/Snitkin-Lab-Umich/regentrans/tree/master/vignettes/manuscript_figures
The example data used in the package and manuscript is from BioProject accession no. PRJNA415194. The specific SRA accession numbers can be found in supplementary file S1. The metadata corresponding to these sequences can be found on the SRA Run Selector (isolate column) and as example data in the regentrans package.
The KPNIH1 sequence was used as the reference genome (SRA accession number SRZ080789)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
ESS received support from the National Institutes of Health under Grant No. 1R01AI148259-01. ZL received support from the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE 1256260. JW received support from the Canadian Institutes of Health Research fellowship [grant number 201711MFE-396343-165736] and the Michigan Institute for Clinical and Health Research (MICHR) Postdoctoral Translational Scholars Program (PTSP). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funding bodies had no role in the design of the study or collection, analysis, and interpretation of data, or in writing the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The original study was reviewed and approved by the Institutional Review Board of the University of Pennsylvania with a waiver of informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Repositories https://github.com/Snitkin-Lab-Umich/regentrans/
Updated text and figures
Data Availability
The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files. The regentrans R package can be downloaded from GitHub: https://github.com/Snitkin-Lab-Umich/regentrans/ The manuscript figures are generated from regentrans example data and can also be found on GitHub: https://github.com/Snitkin-Lab-Umich/regentrans/tree/master/vignettes/manuscript_figures The example data used in the package and manuscript is from BioProject accession no. PRJNA415194. The metadata corresponding to these sequences can be found on the SRA Run Selector (isolate column) and as example data in the regentrans package.
